Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IACH MATH 2020 | Clinical practice recommendation on HSCT for AML with FLT3-internal tandem duplication

Zinaida Perić • 25 Jun 2020
IACH MATH 2020
Acute Myeloid Leukemia Leukemia Anti-thymocyte globulin

Zinaida Perić, MD, PhD, University Hospital Centre Zagreb, School of Medicine, Zagreb, Croatia, outlines the best approaches for hematopoietic stem cell transplantation for acute myeloid leukemia (AML) patients with FLT3-internal tandem duplication. Dr Perić reviews the position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Zinaida Perić

2:34
Advances in chronic GvHD management
Zinaida Perić • 28 Sep 2021
2:56
Ibrutinib, ruxolitinib & belumosudil for SR-cGvHD
Zinaida Perić • 28 Sep 2021
2:13
Next steps in chronic GvHD
Zinaida Perić • 28 Sep 2021
9:45
Management of chronic GvHD
Zinaida Perić • 25 Jun 2020

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals